CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

February 18, 2026 · Phase 2 readout

MRNA Phase 2 readout: a positive outcome, +6.1%

On February 18, 2026, mRNA-1345 — Moderna, Inc. (Respiratory Syncytial Virus) reached its Phase 2 readout. The result was a positive outcome, and the stock moved +6.1% in the window around the event.

The move

$43.93
1d before
$46.60
Event day
$49.70
1d after
$50.29
5d after

Pre-catalyst setup

+1.0%
30-day run-up
7969%
30-day volatility
0.8×
volume spike